StemCell Therapy

New York, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Medicine Market by Product, Route of Administration, Animal Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 20202027" - https://www.reportlinker.com/p05955108/?utm_source=GNW

The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027. Veterinary medicine is defined as a drug or other preparations employed in the treatment of animals. Furthermore, other preparations such as vaccines and medicated feed additives are also used to treat various medical conditions in animals. In addition, these medicines include different type of products such as anti-infective drugs, which are used to prevent, kill, or slow the growth of bacteria, fungi and other infection causing organisms. These medicines also include anti-inflammatory drugs, which are routinely used for relief of pain and inflammation associated with osteoarthritis, and other medical conditions in livestock and companion animals. Furthermore, parasiticide is another type of veterinary drug, which are employed in prevention or elimination of external and internal parasites such as fleas, ticks, and worms. Other than drugs, vaccines are also used in treatment of various medical conditions in animals. Some types of veterinary vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccine. Similarly, medicated feed additives are also used to cure medical conditions in livestock and companion animals. In addition, these different types of drugs are administered to animals through different routes such as oral, parenteral and topical. Furthermore, these drugs are used in treatment of companion animals such as dogs, cats and horses and are also used in treatment of livestock animals such as pigs, dairy cattle, beef cattle, and poultry. The major factors that contribute toward the growth of the veterinary medicine market include rise in number of pet owners and surge in livestock population across the globe. Furthermore, factors such as surge in prevalence of various medical conditions in animals and rise in demand for livestock products also boost growth of the veterinary medicine market. In addition, rise in animal healthcare expenditure is another major factor that fuels growth of the market. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicate feed additives restrict growth of the veterinary medicine market. Conversely, increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market. The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region to provide a detailed assessment of the market. By product, the market is divided into drugs, vaccines, and medicated feed additives. The drugs segment is further divided into anti-infective, anti-inflammatory, and parasiticide. In addition, the vaccines segment is divided into inactivated vaccines, attenuated vaccines, and recombinant vaccines. Similarly, the medicated feed additives segment is divided into amino acids and antibiotics. By route of administration, the market is classified into oral route, parenteral route, and topical route. By animal type, it is divided into companion animals and livestock animals. By distribution channel, it is classified into veterinary hospitals, veterinary clinics, and pharmacies & drug stores. By region, the veterinary medicine market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Sant Animale, Virbac., Vetoquinol S.A., Boehringer Ingelheim International GmbH., ADM Animal Nutrition, and Evonik Industries AG.

KEY BENEFITS FOR STAKEHOLDERS This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments. The market size and estimations are based on a comprehensive analysis of key developments in the industry. A qualitative analysis based on innovative products facilitates strategic business planning. The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments By Product o Drugs - Anti-infective - Anti-inflammatory - Parasiticide o Vaccines - Inactivated Vaccines - Attenuated Vaccines - Recombinant Vaccines o Medicated Feed Additives - Amino Acids - Antibiotics By Route of Administration o Oral Route o Parenteral Route o Topical Route By Route of Administration o Oral Route o Parenteral Route o Topical Route By Animal Type o Companion Animals o Livestock Animals

By Distribution Channel o Veterinary Hospital Pharmacies o Retail Veterinary Pharmacies By Region o North America - U.S. - Canada - Mexico o Europe - Germany - France - UK - Italy - Spain - Rest of Europe o Asia-Pacific - Japan - China - India - Australia - South Korea - Rest of Asia-Pacific

o LAMEA - Brazil - Saudi Arabia - South Africa - Rest of LAMEA List of key players profiled in the report: Zoetis, Inc. Merck & Co., Inc. (Intervet International B.V.) Elanco Animal Health Dechra Pharmaceuticals PLC Ceva Sant Animale Virbac. Vetoquinol S.A. Boehringer Ingelheim International GmbH. ADM Animal Nutrition Evonik Industries AG

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) Pharmgate Inc. Bimedia, Inc.Read the full report: https://www.reportlinker.com/p05955108/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more here:
The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6%...

This entry was posted on September 3, 2020 at 5:52 pm and is filed under Veterinary Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |